erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
check out original content and videos published every day to help you learn about the issues that mean the most to you..
chat with us in facebook messenger. find out what's happening in the world as it unfolds.